PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Public Health Laboratory, Alberta Precision Laboratories, Alberta, Canada.\', \'Department of Pathology and Laboratory Medicine, University of Alberta, Alberta, Canada.\', \'Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.\', \'Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada.\', \'Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.\', \'Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.\', \'Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.\', \'Public Health, Alberta Health Services, Alberta, Canada.\', \'Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1099/jmm.0.001372
?:hasPublicationType
?:journal
  • Journal of medical microbiology
is ?:pmid of
?:pmid
?:pmid
  • 34309503
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.914
?:rankingScore_hIndex
  • 99
?:title
  • Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all